Cardio Diagnostics Holdings (CDIO) Change in Cash (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Change in Cash of $2.0 million for Q1 2026, up 258.0% sequentially from -$1.2 million in Q4 2025, and up 5.65% YoY from $1.9 million in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Change in Cash (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Change in Cash for 6 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Change in Cash rose 5.65% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 132.14% YoY) and the FY2025 annual result came in at -$2.7 million, down 141.52% from the prior year.
- Change in Cash improved to $2.0 million in Q1 2026 per CDIO's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $9.3 million in Q2 2022 and troughed at -$4.8 million in Q4 2022.
- A 5-year average of $386132.6 and a median of -$253020.0 in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 27198.64% in 2022, down 7289.53% in 2022.
- Over 5 years, Change in Cash stood at -$4.8 million in 2022, then soared by 51.59% to -$2.3 million in 2023, then surged by 349.13% to $5.8 million in 2024, then sank by 121.29% to -$1.2 million in 2025, then surged by 258.0% to $2.0 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $2.0 million, -$1.2 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Cardio Diagnostics Holdings | 6.05 Mn | 460,682.10 | - | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.49 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -1.72 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 672,471.00 |
| Jun 30, 2024 | -253,020.00 |
| Mar 31, 2024 | 279,616.00 |
| Dec 31, 2023 | -2.35 Mn |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | -1.66 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | -4.85 Mn |
| Sep 30, 2022 | -696,018.00 |
| Jun 30, 2022 | 9.35 Mn |
| Mar 31, 2022 | -202,526.00 |
| Dec 31, 2021 | 526,625.00 |
| Sep 30, 2021 | 9,681.00 |